Characterization and antibody preparation of the gene products of grouper iridovirus ORF120L
Grouper iridovirus (GIV) is regarded as a prominent viral pathogen of grouper, particularly during the larval and juvenile stages. The aim of this study was to comprehensively characterize the GIV-120L gene during viral infection. The results of sequence analysis suggest that GIV-120L is a 1,470 bp gene encoding a Ranavirus-specific viral protein. Recombinant GIV-120L protein was purified using a nickel-affinity column, and its molecular weight was found to be 59.1 kDa. To obtain antibodies against GIV, mice were immunized with recombinant GIV-120L protein, the spleen was harvested 8 weeks later, and hybridoma testing was performed using Sp2/0 myeloma cells. Polyclonal and monoclonal antibodies against GIV-120L were obtained. To characterize GIV-120L gene expression, grouper kidney (GK) cells were infected with GIV using cycloheximide (CHX) and cytosine arabinoside (AraC). GIV-120L transcripts and protein were found at 12-30 h post infection (hpi) and 18-30 hpi, respectively. In addition, inhibition with CHX and AraC confirmed that GIV-120L was a late gene. Immunofluorescence staining using the antibodies produced in the study confirmed that GIV-120L protein is expressed at viral assembly sites at 24 hpi. The findings of this study provide functional characterization of the GIV-120L viral gene, enhance understanding of GIV assembly, and offer insights for GIV diagnostic applications.
Authors
- Hsiang-Chieh Chuang (ORCID: https://orcid.org/0000-0001-7713-0979)
- Chu‐Fan Cheng
- Yu‐Shen Lai
Institutions
- University of Science and Technology (YE)
- National Kaohsiung Marine University (TW)
- National Kaohsiung University of Science and Technology (TW)
- National Ilan University (TW)
Publication Details
- Journal
- Virus Research
- Published
- 2025-08-25
- DOI
- https://doi.org/10.1016/j.virusres.2025.199625
- Primary Topic
- Virus-based gene therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00